DNA2 0 INC has a total of 19 patent applications. Its first patent ever was published in 2014. It filed its patents most often in United States, Canada and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, foods and drinks and pharmaceuticals are BALLIVET MARC, FLASH THERAPEUTICS and SYNPLOID BIOTEK LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Canada | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Foods and drinks | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Enzymes | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Minshull Jeremy | 19 |
#2 | Govindrajan Sridhar | 17 |
#3 | Welch Mark | 16 |
#4 | Caves Kate | 16 |
#5 | Lee Maggie | 11 |
#6 | Ness Jon | 9 |
#7 | Patel Kedar | 1 |
Publication | Filing date | Title |
---|---|---|
US2017101646A1 | DNA vectors, transposons and transposases for eukaryotic genome modification | |
EP3359671A2 | Dna vectors, transposons and transposases for eukaryotic genome modification | |
WO2015157579A2 | Enhanced nucleic acid constructs for eukaryotic gene expression | |
US2015225730A1 | Methods for generating libraries with co-varying regions of polynuleotides for genome modification |